Pipeline

•CB-101, a first-in-class TSA+TAA AND gate trispecific TCE for colon, pancreatic, lung cancers

•CB-201, a best-in-class CD3+CD28 costimulatory trispecific TCE for breast, ovarian cancers 

•CB-302, A best-in-class B cell TAA1+TAA2 OR gate trispecific TCE for hematologic malignancies or autoimmune diseases

•CB-401, a first-in-class TAA1+TAA2 AND gate trispecific TCE for lung, colon, TNBC cancers

•CB-501, a first-in-class Masked TAA+CD3/CD28 Contexual gate trispecific TCE for lung, colon, head & neck cancers